India Exchange Filings

Windlas Biotech Q2 FY27 Results and Board Highlights

Windlas Biotech Ltd approves Q2 FY27 results, with revenue of ₹263.91 crore and net profit of ₹18.05 crore

  • Revenue rose 6.4% QoQ and 18.7% YoY; net profit increased 2.3% QoQ and 1.4% YoY. Calculated EBIT margin was 8.3%.
  • Ashok Kumar Windlass resigned as whole-time director and director effective November 5; appointed Founder President and senior management personnel from November 6, subject to shareholder approval.
  • Hitesh Windlass was appointed Chairman effective November 5. Auditors issued an unmodified limited-review conclusion.

Original Filing

This is an automated summary of a public document. Always check the original before relying on it.